Bravida Q2 2025 slides: Profitability improves despite sales decline

Bravida Holding AB (STO:BRAV) reported Q2 2025 results demonstrating improved profitability despite a 9% decline in net sales, with EBITA margin rising to 5.4% from 4.5% as the Nordic technical service provider prioritizes margins over volume in a challenging market. While net sales decreased to SEK 6,974 million, order intake increased 9% year-over-year, notably driven by strong performance in Denmark. The company plans to maintain its project-selective strategy and focus on cost control amidst anticipated ongoing market challenges, particularly in the installation business, reinforcing its margin-over-volume approach.

Analysis

Bravida Holding AB's (BRAV) Q2 2025 results demonstrate a successful execution of its 'margin over volume' strategy amidst a challenging Nordic market. Despite a 9% year-over-year decline in net sales to SEK 6,974 million, driven by an 8% organic contraction, the company improved its EBITA margin significantly to 5.4% from 4.5% in the prior year. This profitability enhancement was largely propelled by a remarkable turnaround in Denmark, where the EBITA margin surged to 4.3% from just 0.1% in Q2 2024, and supported by margin improvements in Sweden and Norway. A key forward-looking indicator, order intake, rose 9% year-over-year, bolstering the order backlog and suggesting future revenue potential, particularly driven by a large industrial contract in Denmark. However, weaker cash conversion, which fell to 80% from 112%, and increased leverage, with net debt/EBITDA rising to 1.4x from 1.1x, represent areas for monitoring. The company's outlook reinforces the expectation of a 'transition year,' with the steeper sales decline in Q2 compared to Q1 indicating that market pressures, especially in the installation business, persist.

Key Decisions for Investors

• Investors should recognize that Bravida's demonstrated ability to expand margins during a sales downturn validates its strategic focus on profitability, potentially warranting a re-evaluation of the stock's resilience.
• Monitor future order intake and backlog trends closely, as sustained growth in these leading indicators, particularly outside of Denmark, would signal a potential bottoming of the market and a catalyst for revenue recovery.
• Closely track the resolution of the noted large unpaid receivables and the normalization of cash conversion, as a failure to improve from the current 80% level could indicate deeper project-related risks not fully captured by margin figures.
• Consider the divergent regional performance a key risk factor; while Denmark's recovery is a strong positive, continued weakness in Finland and the significant 18% sales decline in Norway warrant a cautious stance until a broader-based stabilization is evident.